causes an immunosuppressive disease in young chickens. In the United States, the disease often is subclinical, but IBDV strains exist elsewhere which can cause high mortality. These strains are commonly referred to as very virulent IBDV (vvIBDV).
Diagnosis of IBDV strains is important because differences exist in their ability to cause disease and their antigenic types. A molecular assay designated as the RT/PCR-RFLP (reverse transcriptase/ polymerase chain reaction-restriction fragment length polymorphism) has been used to diagnose IBDV and identify specific viral strains. This molecular assay can be used to place viruses into geneticallyrelated groups called molecular groups.
The molecular groups observed for vaccine and laboratory strains are shown in Table 1 (next page) . IBDV strains within a group are antigenically related. Molecular groups 1 and 2 contain variant viruses; groups 3, 4 and 6 contain classic viruses, and group 5 contains the Lukert strain viruses.
The six molecular groups in Table 1 were identified because of differences in the genetic material of the viruses. The RT/PCR part of the molecular assay amplifies the genetic material of the viruses so it can be detected. The amplified genetic material then is cut into pieces, the sizes of which are different for each virus because their genetic material is unique. The fragments of genetic material can be detected and their sizes recorded for each IBDV strain tested. The various fragments observed for a given virus are called RFLP patterns. Figure 1 shows the RFLP patterns of the six molecular groups identified in IBDV vaccine strains. The BstNI (B) and Mbol (M) enzymes were used to cut the RT/PCR products. Each band represents a restriction fragment, the length of which is determined by comparing it to the DNA size ladder (L).
No. 62
November 1998 The size in base pairs of each band in the DNA ladder is listed at the left of Figure 1 . The lengths of the DNA fragments for each molecular group are listed in Table 1 . It can be seen that some IBDV strains have identical BstNI patterns. When this is observed, the Mbol pattern is used to differentiate the viruses.
Molecular
Procedures used to conduct the RT/PCR-RFLP assay have been standardized. The entire procedure takes approximately 72 hours, and can be conducted on any bursal tissue thought to be infected with IBDV. The test is designed so that all IBDV strains will be detected, regardless of their virulence or antigenic type.
We developed a procedure that makes it possible to import IBDV-infected bursal tissue into the United States for testing. The method inactivates the virus, but preserves the viral genetic material used in the assay.
The RFLP patterns appear to be very stable, even when a virus is passaged many times in a host. We have observed some minor changes in the RFLP patterns when a virus is adapted to replicate in a new host. This can be seen in Molecular Group 1 (Table 1 ). The 1084AEP5 virus that was adapted to replicate in embryonated eggs has a minor shift in one of the Bst NI bands.
A POWERFUL TOOL
The RT/PCR-RFLP assay is a powerful tool because it not only can detect IBDV in a chicken flock, it also can identify genetic properties of the virus that are consistent with antigenic type and the very virulent pathotype.
What does it mean when we find viruses that do not match any of the molecular groups described in Table 1? These viruses represent field strains usually called wild-type viruses. They have the genetic potential to become new antigenic types. If antibody titers to IBDV are high in a flock where a wild-type virus is found, this suggests that the vaccine being used is not the appropriate antigenic type, and switching to a different vaccine may be beneficial. The actual benefit can be determined only by making the switch, or by vaccination challenge experiments with the wild-type strain.
A poultry company that uses RFLP to monitor flocks can generate a data base of wild-type RFLP patterns and, using the vaccination history of the flocks, can determine for itself which vaccines appear to work well against specific wild-type viruses.
It is possible, however, that no benefit will be observed from a vaccine switch because the wild-type virus is a new antigenic type. In that case, a new vaccine prepared from the wild-type virus is warranted. s Table 1 Results of the RT/PCR-RFLP assay for vaccine and laboratory strains of IBDV Information from the RT/PCR-RFLP assay has been used to evaluate vaccination programs. After a vaccination program is implemented, chicken flocks can be monitored using the RT/PCR-RFLP assay to identify the presence of the vaccine strain in the vaccinated birds. The infection rate and spread of vaccine virus can be monitored within a flock and between flocks. Since this assay detects the viral genome, the presence of the IBDV vaccine in a flock can be confirmed without waiting for serum antibodies to be produced.
The assay can be used to monitor flocks for new IBDV strains and potentially pathogenic viruses. Since the RFLP profiles of most vaccine strains are known, any virus detected in a flock with a new RFLP could be a new strain that should be investigated further.
The spread of a virus between flocks, houses and farms can be determined using the RT/PCR-RFLP assay.
The is known as epidemiology and the information generated can be used to assess traffic patterns and other biosecurity measures.
Biologics companies can use RFLP to insure the authenticity of their vaccines. Quality control is an important part of vaccine development and production. The RT/PCR-RFLP assay has been used to identify vaccine strains of IBDV and to insure their authenticity in vaccine lots and master seeds. This is very important when more than one virus is being used in a vaccine preparation or when an autogenous vaccine is being developed.
The very virulent pathotype of IBDV can be predicted by including a third enzyme in the RFLP analysis.
This third enzyme is Sspl and the site where this enzyme cuts is present in the genome of vvIBDV strains. 
TROUBLESHOOTING BROILER PERFORMANCE
History: A multicomplex U.S. broiler integrator had one complex (A) where feed conversion and growth rate were below that of other broiler operations in the same region. To determine the importance and effect of IBD on broiler performance, 10 bursae were collected from 1-5 flocks in each of nine complexes between 14-28 days of age. nearby company, Complex B, which was not experiencing performance problems.
Bursal histologic lesions:
These were very similar in the samples from the two COMPANY  #1  #2  #3  #4  #5  #6  #7  #8  #9 Body weight gain post-challenge also was measured (Table 4) . Weight gain was found to be the least depressed in birds challenged with "molecular variant #6".
Conclusion:
IBD histologic lesions were no more severe in broilers from Complex A, which had relatively poorer performance, than in Complex B which had no performance problems. Predominant IBD "molecular variant #6" found in Complex A was not clinically different (% protection, weight gain depression) from Del E. Use of molecular IBD identification and bursa histology clearly shows that IBD was not a major contributing factor to the poorer feed conversion and growth rate at Complex A.
DETERMINING WHICH IBD VACCINE TO USE
A Molecular Identification Survey was conducted in the United States in 1997-1998, involving 78 flocks from six companies. The samples were from 18 broiler complexes located in 10 states (Table 5 ). Ten bursae per broiler flock were sampled at a target age of 14-28 days. complexes (Table 1) . Two broiler flocks in each complex had histologic damage. Lesions actually were more severe in Complex B where no performance problems were observed. Table 2 , presence and molecular identification were determined using the method described by Dr. Jackwood in the forward section of this issue. 84% of the flocks sampled had an IBD isolate. The only known IBD subtype identified was Del E (37.5%). No "Classic" or Del A was identified. Eight "molecular variants" were found. Complex A had only "molecular variant #6" in 74% of the broiler flocks sampled.
IBD isolates: As shown in

IMPORTANCE OF "MOLECULAR VARIANT" FOUND
IBD "molecular variant #6" from Complex A was used as a challenge virus in addition to "Classic" (APHIS challenge strain) and variant Del E. The IBD virus was used against chicks from five breeder flocks, using the protocol described in Vineland Update No. 60 (January, 1998).
Maternal antibody protection (bursa/body weight ratio or histologic score) of birds challenged with "molecular variant #6" was Molecular identification was performed on bursae as described by Dr. Jackwood in the accompanying article.
IBD Isolates were found in 69.2% of the broiler flocks sampled. Del E was the predominant known serotype found, representing 19.2%. In lower numbers and primarily in the southwest and northwest regions of the U.S. respectively, other known serotypes were identified, i.e., Lukert, 5.1% and "Classic" 3.9%. Most of the isolates, however, were "molecular variants", 53.6%. In total, 10 different subtypes were classified.
Conclusions:
This survey suggests that most U.S. companies need a Del E-like subtype in their breeder or broiler vaccination programs for adequate protection of broilers. In the southwestern and northwestern production areas, the Lukert and "Classic" IBD subtypes appear to be required.
The importance of "molecular variants" needs to be determined in birds. One method is to challenge with virus as described in the "Troubleshooting" section above. 
